Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-06-18FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the la…
-
CLINICAL_TRIALS trial_result · 2009-06-16Clinical Trial Update: Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients [Phase 2]
Phase 2 study evaluating the efficacy and safety of finafloxacin in patients with Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-08Clinical Trial Update: Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection [NA]
This is an update on a completed clinical trial evaluating quadruple therapy for Helicobacter pylori infections resistant to triple therapy.
-
FDA approval · 2009-03-04FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for Clarithromycin from Sandoz Inc, granting approval to a generic version under an ANDA.
-
CLINICAL_TRIALS trial_result · 2009-03-03Clinical Trial Update: Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection [Phase 4]
A Phase 4 clinical trial assessed whether a patient's metabolic rate affects the eradication of Helicobacter pylori with omeprazole in duode…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-02-05Clinical Trial Update: The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
A clinical trial update examining how Helicobacter pylori infection, bacterial density, and gastric histology change after antrectomy.
-
FDA approval · 2009-02-02FDA Approved: AMOXICILLIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for amoxicillin from Teva Pharmaceuticals USA, Inc., resulting in updated labeling and specification…
-
CLINICAL_TRIALS trial_result · 2009-01-14Clinical Trial Update: The Effect of Radioactive Iodine Administration for Thyroid Diseases on H.Pylori Eradication
This clinical trial update reports on the effect of radioactive iodine treatment for thyroid diseases on the eradication of Helicobacter pyl…
-
FDA approval · 2008-09-18FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Clarithromycin from Sandoz Inc, marking regulatory clearance for changes to this generic ant…
-
CLINICAL_TRIALS trial_result · 2008-07-30Clinical Trial Update: The Effect of H. Pylori Infection on Iron Metabolism [Phase 2, Phase 3]
This update reports the completion of a Phase 2/Phase 3 trial evaluating how Helicobacter pylori infection affects iron metabolism.
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: First Time in Man Study of Finafloxacin Hydrochloride [Phase 1]
First-in-man Phase 1 trial update for finafloxacin hydrochloride, evaluating safety and pharmacokinetics in humans for Helicobacter pylori i…
-
CLINICAL_TRIALS trial_result · 2008-07-21Clinical Trial Update: Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia [Phase 3]
Phase 3 trial completed evaluating regimens containing clarithromycin, amoxicillin, and metronidazole for Helicobacter pylori infection in C…
-
FDA approval · 2008-04-21FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID (lansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-21FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for PREVACID SOLUTAB (lansoprazole) filed by Takeda Pharmaceuticals America, expanding the product's…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Helicobacter Pylori and Dry Eye
Clinical trial update shows completion of a study examining the relationship between Helicobacter pylori infection and dry eye disease.
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Breath Ammonia Method for H. Pylori Detection: Phase II [Phase 2]
Phase II trial completed evaluating a breath ammonia method for detecting Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2007-12-18Clinical Trial Update: Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients [Phase 4]
Phase 4 clinical trial update on management strategies for using esomeprazole (Nexium) in patients infected with Helicobacter pylori, in the…
-
FDA approval · 2007-10-22FDA Approved: OMEPRAZOLE — Original Application (Apotex Corp)
FDA approved Apotex Corp's original application for a generic omeprazole product, enabling a generic option for treating gastroesophageal re…
-
FDA approval · 2007-10-22FDA Approved: OMEPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original (ANDA) application for omeprazole from Quallent Pharmaceuticals Health LLC, authorizing a generic omeprazole produ…
-
FDA approval · 2007-10-17FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Clarithromycin submitted by Sandoz Inc, granting a supplemental approval for the product.
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).
-
CLINICAL_TRIALS research · 2007-08-14Clinical Trial Update: Effect of Helicobacter Pylori on the Availability of Vitamin E and C [Phase 4]
Phase 4 trial update investigating whether Helicobacter pylori infection affects the availability of vitamins E and C. Sponsor: University o…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Helicobacter Pylori and Acute Alcohol Induced Pancreatitis
A Tampere University-sponsored clinical trial examining the relationship between Helicobacter pylori infection and acute alcohol-induced pan…
-
FDA label_change · 2007-05-24FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for the combination drug Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochlor…
-
FDA approval · 2007-04-27FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca, resulting in updated labeling.